Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$13.07 -0.11 (-0.83%)
As of: Oct 1, 2026 · 2:59 PM EDT

Enanta Pharmaceuticals (ENTA) Shares Outstanding (Entity) (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) reported Shares Outstanding (Entity) of 29.12 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 36.2% from 21.38 million a year earlier and up 0.2% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals posted Shares Outstanding (Entity) of 21.39 million, up 0.9% from FY2024.

  • Shares Outstanding (Entity) has increased for 14 consecutive fiscal years, with a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
  • By fiscal year, Shares Outstanding (Entity) came in at 21.19 million in FY2024 (+0.6%), 21.06 million in FY2023 (+1.3%), 20.79 million in FY2022 (+2.7%) and 20.24 million in FY2021 (+0.8%).
  • The fiscal Q3 2026 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q2 2012.
  • Year over year, Shares Outstanding (Entity) has now increased in each of the last 50 quarters, with growth averaging 14.1% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 0.6% in fiscal Q3 2024 to 36.2% in fiscal Q3 2026.
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at 29.06 million (Q2 2026), 29.02 million (Q1 2026) and 21.39 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Enanta Pharmaceuticals 383.80 Mn -344.19 Mn - 29.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.12 Mn
Mar 31, 2026 29.06 Mn
Dec 31, 2025 29.02 Mn
Sep 30, 2025 21.39 Mn
Jun 30, 2025 21.38 Mn
Mar 31, 2025 21.38 Mn
Dec 31, 2024 21.33 Mn
Sep 30, 2024 21.19 Mn
Jun 30, 2024 21.18 Mn
Mar 31, 2024 21.18 Mn
Dec 31, 2023 21.16 Mn
Sep 30, 2023 21.06 Mn
Jun 30, 2023 21.06 Mn
Mar 31, 2023 21.05 Mn
Dec 31, 2022 20.88 Mn
Sep 30, 2022 20.79 Mn
Jun 30, 2022 20.72 Mn
Mar 31, 2022 20.62 Mn
Dec 31, 2021 20.51 Mn
Sep 30, 2021 20.24 Mn
API Access

Enanta Pharmaceuticals Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ENTA&period=max&api_key=YOUR_API_KEY